Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.07
Delayed Data
As of Jul 22
 -0.023 / -2.10%
Today’s Change
0.64
Today|||52-Week Range
1.99
-24.11%
Year-to-Date
Relative to its peers, XTLB does not have very much institutional sponsorship. The 8.97% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Other institutional7.71%
Mutual fund holders1.26%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of X T L Biopharmaceuticals Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC7.59%1,040,1941,206,625-71,768-6.45%
Invesco Asset Management Ltd.0.95%129,811150,58100.00%
IBI Mutual Funds Management (1978...0.29%40,30046,74800.00%
Citadel Advisors LLC0.12%15,85818,395+15,858--
U-Bank Mutual Funds Ltd.0.02%2,6153,03300.00%
Tower Research Capital LLC0.01%800928+700+700.00%
UBS Securities LLC0.00%00-363-100.00%
Morgan Stanley & Co. LLC0.00%8900.00%

Top 10 Mutual Funds Holding X T L Biopharmaceuticals Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Perpetual Income & Growth Investm...0.72%98,013113,69500.00%
I.B.I. Foreign Equity Liable0.29%40,30046,74800.00%
Keystone Investment Trust Plc0.19%25,84029,97400.00%
Invesco Perpetual UK 2 Invt. Seri...0.04%5,9586,91100.00%
Modus Menayot Clali0.02%2,6153,03300.00%